Literature DB >> 912905

Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes.

P A Bond, R L Cundall.   

Abstract

The properties of monoamine oxidase in plasma, platelets, lymphocytes and granulocytes have been studied using cells prepared from a single small (about 20 ml) sample of blood. The three substrates, 5-hydroxytryptamine, tyramine and benzylamine, have been used to obtain a more complete picture of blood monoamine oxidase than was previously possible. Measurement of Michaelis constants, use of selective inhibitors, and activity against the three substrates distinguished three types of activity. The monoamine oxidases in platelets and lymphocytes are very similar, being most active with tyramine or benzylamine as substrate and inhibited by low concentrations of deprenil. The enzymes in plasma and granulocytes are similar in their relatively high activity against 5-hydroxytryptamine and in their inhibition by semicarbazide and cuprizone with tyramine or benzylamine as substrates. They differ in their affinities for 5-hydroxytryptamine and their activity against tyramine. The activity in platelets, plasma, lymphocytes and granulocytes has been measured in a group of 15 normal subjects using three substrates.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912905     DOI: 10.1016/0009-8981(77)90039-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Authors:  A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Authors:  D L Murphy; K B Sims; F Karoum; N A Garrick; A de la Chapelle; E M Sankila; R Norio; X O Breakefield
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Screen for MAOA mutations in target human groups.

Authors:  D E Schuback; E L Mulligan; K B Sims; E A Tivol; B D Greenberg; S F Chang; S L Yang; Y C Mau; C Y Shen; M S Ho; N H Yang; M G Butler; S Fink; C E Schwartz; F Berlin; X O Breakefield; D L Murphy; Y P Hsu
Journal:  Am J Med Genet       Date:  1999-02-05

5.  Human monoamine oxidase A gene determines levels of enzyme activity.

Authors:  G S Hotamisligil; X O Breakefield
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

6.  Molecular properties of monoamine oxidases A and B.

Authors:  S W Kwan; J M Bergeron; C W Abell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Structure and promoter organization of the human monoamine oxidase A and B genes.

Authors:  J C Shih; J Grimsby; K Chen; Q S Zhu
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

Review 8.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

9.  Norrie disease gene is distinct from the monoamine oxidase genes.

Authors:  K B Sims; L Ozelius; T Corey; W B Rinehart; R Liberfarb; J Haines; W J Chen; R Norio; E Sankila; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

10.  Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1.

Authors:  Wai K Wong; Xiao-Ming Ou; Kevin Chen; Jean C Shih
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.